← All trials
NCT07023302
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 19, 2025
- Primary completion
- Feb 28, 2029
- Completion date
- Feb 28, 2029
- First posted
- Jun 16, 2025
- Last posted
- Aug 26, 2025
- Enrollment
- 123
- Arms / groups
- 10 / —
- Source
- AACT · ctgov ingestion
Sponsors
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.